Stock Information
Intellia Therapeutics Inc (NTLA)
Ticker Symbol: NTLA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,670.27 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.8262
Revenue (TTM): $0.58 M
Dividend Yield: N/A%
ROE: -56.63%
Latest News
-
Bernstein Maintains Market Perform on Intellia Therapeutics, Raises Price Target to $17
Wed, May 13, 2026 2:39 PM
-
Aramark To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Wed, May 13, 2026 9:03 AM
-
HC Wainwright & Co. Maintains Buy on Intellia Therapeutics, Lowers Price Target to $25
Wed, May 13, 2026 7:05 AM
-
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2026 Update
Tue, May 12, 2026 11:54 PM
-
Intellia Therapeutics, Inc. (NTLA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Tue, May 12, 2026 9:40 PM
-
Transcript : Intellia Therapeutics, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03
Tue, May 12, 2026 9:35 PM
-
Canaccord Genuity Maintains Buy on Intellia Therapeutics, Lowers Price Target to $49
Tue, May 12, 2026 5:23 PM
-
Wedbush Reiterates Neutral on Intellia Therapeutics, Maintains $12 Price Target
Tue, May 12, 2026 8:44 AM
-
Intellia Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
Mon, May 11, 2026 9:35 AM
-
Intellia Therapeutics Q1 EPS $(0.81) Beats $(0.90) Estimate, Sales $15.048M Beat $14.793M Estimates
Mon, May 11, 2026 7:49 AM
Key Financials
Financial data not available
